Quick Answer
Benitec Biopharma Inc. reported Earnings Per Share Diluted of $1.05 (loss) per share for the year ending 2025.
- Benitec Biopharma Inc. showed an increase of +13.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Benitec Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Benitec Biopharma Inc.'s Earnings Per Share Diluted has grown by 67.5%.
- Historical annual values: Fiscal year 2025: $1.05 (loss) per share | Fiscal year 2024: $1.22 (loss) per share | Fiscal year 2023: $14.12 (loss) per share | Fiscal year 2022: $37.88 (loss) per share | Fiscal year 2021: $3.23 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: